Bandingkan Harga & Kinerja Lippo Cikarang Tbk (LPCK) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Lippo Cikarang Tbk dan Organon Pharma Indonesia Tbk.: Lippo Cikarang Tbk diperdagangkan di Rp595 (kapitalisasi pasar 3,03 T, volume 24 jam 360,2 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Lippo Cikarang Tbk jauh lebih besar — sekitar 29× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| LPCK | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 3,03 T | 104,4 M |
Volume | 360,2 rb | — |
Lot | 3,6 rb | — |
Perputaran | 208,09 jt | — |
Harga Rata-rata | 577,7 | — |
Nilai Transaksi | 208,09 jt | — |
Harga Ekuilibrium Indikatif | 595 | — |
Volume Ekuilibrium Indikatif | 2 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Lippo Cikarang Tbk
PT Lippo Cikarang Tbk was established in the Republic of Indonesia the framework of the Domestic Capital Investment Law on July 20, 1987 based on Notarial Deed No.43 of Hendra Karyadi, S.H., as amended by Notarial Deed No. 63 of the same notary dated April 22, 1998.
Selengkapnya di halaman LPCK →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
